A Randomized, Open Label, Two-Arm, Cross-Over Design Study to Compare the Pharmacodynamics and Pharmacokinetics of Insulin Glulisine and Insulin Lispro in Obese Patients With Type 2 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 22 Sep 2009
At a glance
- Drugs Insulin glulisine; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- Sponsors Sanofi
- 22 Sep 2009 Actual initiation date (Nov 2004) added as reported by ClinicalTrials.gov.
- 12 Sep 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History